spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Tag: Patients still benefit from Eisai and Biogen Alzheimer's drug after four years

Patients still benefit from Eisai and Biogen Alzheimer’s drug after four years, study finds

-Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four...